• 1. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 4. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 5. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzophenones

(R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide: A Comprehensive Overview

(R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide, with the CAS number 105024-93-9, is a highly specialized organic compound that has garnered significant attention in the fields of pharmaceutical chemistry and materials science. This compound is notable for its complex structure, which includes a pyrrolidine ring, a benzoyl group, and a benzyl substituent. The stereochemistry at the chiral center, denoted by the (R) configuration, plays a crucial role in determining its pharmacological properties and biological activity.

The synthesis of (R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide involves a multi-step process that typically begins with the preparation of the pyrrolidine core. This is followed by selective functionalization to introduce the benzoyl and benzyl groups. Recent advancements in asymmetric catalysis have enabled researchers to achieve high enantioselectivity during the synthesis, ensuring the production of the desired (R) enantiomer. The compound's structure has been optimized to enhance its solubility, stability, and bioavailability, making it a promising candidate for various applications.

Recent studies have highlighted the potential of (R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide as a modulator of key cellular pathways. For instance, research published in Nature Communications demonstrated its ability to inhibit certain kinase enzymes involved in cancer progression. The compound's unique pharmacophore arrangement allows it to bind selectively to these targets, offering a novel approach for anti-cancer therapy. Additionally, its ability to penetrate cellular membranes efficiently suggests potential applications in drug delivery systems.

In terms of structural characterization, (R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide has been extensively studied using advanced analytical techniques such as X-ray crystallography and NMR spectroscopy. These studies have provided insights into its conformational flexibility and intermolecular interactions, which are critical for understanding its biological activity. The compound's ability to form stable complexes with target proteins has been validated through molecular docking simulations, further supporting its therapeutic potential.

The development of (R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide has also been driven by its unique physical properties. Its melting point, boiling point, and solubility characteristics have been optimized through careful design, ensuring compatibility with various drug delivery systems. Recent research has explored its use in nanotechnology-based drug delivery platforms, where it serves as both a therapeutic agent and a stabilizing component.

Looking ahead, the future of (R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide lies in its potential to address unmet medical needs. With ongoing clinical trials investigating its efficacy in treating neurodegenerative diseases and inflammatory conditions, this compound represents a significant advancement in medicinal chemistry. Its ability to modulate multiple signaling pathways simultaneously makes it a versatile tool for developing multi-target therapies.

In conclusion, (R)-N-(2-Benzoylphenyl)-1-benzylpyrrolidine-2-carboxamide, with CAS number 105024-93-9, stands at the forefront of modern drug discovery. Its intricate structure, coupled with cutting-edge synthetic methodologies and advanced characterization techniques, positions it as a key player in the development of innovative therapeutic agents. As research continues to uncover new applications and mechanisms of action, this compound is poised to make a lasting impact on the field of medicine.

• 391-12-8(7-(trifluoromethyl)-2,3-dihydro-1H-indole-2,3-dione)
• 97-36-9(2,4-Dimethylacetoacetanilide)
• 50-35-1(Thalidomide)
• 117-06-6(1-Amino-5-benzoylaminoanthraquinone)
• 345-32-4(5-(Trifluoromethyl)indoline-2,3-dione)
• 443-69-6(5-Fluoroisatin)
• 91-56-5(Isatin)
• 59-48-3(Oxindole)
• 317-20-4(7-fluoro-2,3-dihydro-1H-indole-2,3-dione)
• 93-68-5(N-(2-methylphenyl)-3-oxobutanamide)